GSK

Welcome to Haleon. Were a purpose-driven world-class consumer company putting everyday health in the hands of just three years since our launch weve grown evolved and are now entering an exciting new chapter one filled with bold ambitions and enormous opportunity.Our trusted portfol

Welcome to Haleon. Were a purpose-driven world-class consumer company putting everyday health in the hands of just three years since our launch weve grown evolved and are now entering an exciting new chapter one filled with bold ambitions and enormous opportunity.Our trusted portfol

Business Introduction:GSK remains committed to achieving bold commercial ambitions for the future. By 2031 we aim to deliver 40 billion in annual sales leveraging our existing strong performance momentum to significantly increase our positive impact on the health of billions of patien

Business Introduction:GSK remains committed to achieving bold commercial ambitions for the future. By 2031 we aim to deliver 40 billion in annual sales leveraging our existing strong performance momentum to significantly increase our positive impact on the health of billions of patien

Welcome to Haleon. Were a purpose-driven world-class consumer company putting everyday health in the hands of just three years since our launch weve grown evolved and are now entering an exciting new chapter one filled with bold ambitions and enormous opportunity.Our trusted portfol

Welcome to Haleon. Were a purpose-driven world-class consumer company putting everyday health in the hands of just three years since our launch weve grown evolved and are now entering an exciting new chapter one filled with bold ambitions and enormous opportunity.Our trusted portfol

Business IntroductionGSK remains committed to achieving bold commercial ambitions for the future. By 2031 we aim to deliver 40 billion in annual sales leveraging our existing strong performance momentum to significantly increase our positive impact on the health of billions of patient

Business IntroductionGSK remains committed to achieving bold commercial ambitions for the future. By 2031 we aim to deliver 40 billion in annual sales leveraging our existing strong performance momentum to significantly increase our positive impact on the health of billions of patient

Business IntroductionGSK remains committed to achieving bold commercial ambitions for the future. By 2031 we aim to deliver 40 billion in annual sales leveraging our existing strong performance momentum to significantly increase our positive impact on the health of billions of patient

Business IntroductionGSK remains committed to achieving bold commercial ambitions for the future. By 2031 we aim to deliver 40 billion in annual sales leveraging our existing strong performance momentum to significantly increase our positive impact on the health of billions of patient

The Global Supply Chain (GSC) Strategy team designs the supply chains to bring GSKs medicines and vaccines to patients. The Strategy team is responsible for product and network strategy (including the delivery of strategic programmes).The Strategy Team has a clear ambition to be the B

The Global Supply Chain (GSC) Strategy team designs the supply chains to bring GSKs medicines and vaccines to patients. The Strategy team is responsible for product and network strategy (including the delivery of strategic programmes).The Strategy Team has a clear ambition to be the B

GSK Procurement operates globally across 50 countries partnering with business and suppliers to drive value and innovation. We enable GSKs purpose by providing access to world-class goods and services that underpin our portfolio serving billions of patients worldwide.The Global Procur

GSK Procurement operates globally across 50 countries partnering with business and suppliers to drive value and innovation. We enable GSKs purpose by providing access to world-class goods and services that underpin our portfolio serving billions of patients worldwide.The Global Procur

Welcome to Haleon. Were a purpose-driven world-class consumer company putting everyday health in the hands of just three years since our launch weve grown evolved and are now entering an exciting new chapter one filled with bold ambitions and enormous opportunity.Our trusted portfol

Welcome to Haleon. Were a purpose-driven world-class consumer company putting everyday health in the hands of just three years since our launch weve grown evolved and are now entering an exciting new chapter one filled with bold ambitions and enormous opportunity.Our trusted portfol

Welcome to Haleon. Were a purpose-driven world-class consumer company putting everyday health in the hands of just three years since our launch weve grown evolved and are now entering an exciting new chapter one filled with bold ambitions and enormous opportunity.Our trusted portfol

Welcome to Haleon. Were a purpose-driven world-class consumer company putting everyday health in the hands of just three years since our launch weve grown evolved and are now entering an exciting new chapter one filled with bold ambitions and enormous opportunity.Our trusted portfol

Welcome to Haleon. Were a purpose-driven world-class consumer company putting everyday health in the hands of just three years since our launch weve grown evolved and are now entering an exciting new chapter one filled with bold ambitions and enormous opportunity.Our trusted portfol

Welcome to Haleon. Were a purpose-driven world-class consumer company putting everyday health in the hands of just three years since our launch weve grown evolved and are now entering an exciting new chapter one filled with bold ambitions and enormous opportunity.Our trusted portfol

Are you ready to drive business growth in hematology oncology while accelerating access to innovative medicines for patientsJob PurposeGSK is looking to hire a Therapeutic Specialist Oncology (Hematology) to join our Oncology (Hematology) team. This role is a field-based 15-month cont

Are you ready to drive business growth in hematology oncology while accelerating access to innovative medicines for patientsJob PurposeGSK is looking to hire a Therapeutic Specialist Oncology (Hematology) to join our Oncology (Hematology) team. This role is a field-based 15-month cont

Are you a strategic and results-driven marketing professional with a passion for vaccines and driving impactful brand strategies in a dynamic cross-functional environmentGSK remains committed to achieving bold commercial ambitions for the future. By 2031 we aim to deliver 40 billion i

Are you a strategic and results-driven marketing professional with a passion for vaccines and driving impactful brand strategies in a dynamic cross-functional environmentGSK remains committed to achieving bold commercial ambitions for the future. By 2031 we aim to deliver 40 billion i

GSKs success absolutely depends on our people. While getting ahead of disease together is about our ambition for patients and shareholders its also about making GSK a place where people can thrive. We want GSK to be a place where people feel inspired encouraged and challenged to be th

GSKs success absolutely depends on our people. While getting ahead of disease together is about our ambition for patients and shareholders its also about making GSK a place where people can thrive. We want GSK to be a place where people feel inspired encouraged and challenged to be th

Business IntroductionGSK remains committed to achieving bold commercial ambitions for the future. By 2031 we aim to deliver 40 billion in annual sales leveraging our existing strong performance momentum to significantly increase our positive impact on the health of billions of patient

Business IntroductionGSK remains committed to achieving bold commercial ambitions for the future. By 2031 we aim to deliver 40 billion in annual sales leveraging our existing strong performance momentum to significantly increase our positive impact on the health of billions of patient

Business IntroductionGSK remains committed to achieving bold commercial ambitions for the future. By 2031 we aim to deliver 40 billion in annual sales leveraging our existing strong performance momentum to significantly increase our positive impact on the health of billions of patient

Business IntroductionGSK remains committed to achieving bold commercial ambitions for the future. By 2031 we aim to deliver 40 billion in annual sales leveraging our existing strong performance momentum to significantly increase our positive impact on the health of billions of patient

Business IntroductionGSK remains committed to achieving bold commercial ambitions for the future. By 2031 we aim to deliver 40 billion in annual sales leveraging our existing strong performance momentum to significantly increase our positive impact on the health of billions of patient

Business IntroductionGSK remains committed to achieving bold commercial ambitions for the future. By 2031 we aim to deliver 40 billion in annual sales leveraging our existing strong performance momentum to significantly increase our positive impact on the health of billions of patient

Business IntroductionGSK remains committed to achieving bold commercial ambitions for the future. By 2031 we aim to deliver 40 billion in annual sales leveraging our existing strong performance momentum to significantly increase our positive impact on the health of billions of patient

Business IntroductionGSK remains committed to achieving bold commercial ambitions for the future. By 2031 we aim to deliver 40 billion in annual sales leveraging our existing strong performance momentum to significantly increase our positive impact on the health of billions of patient

Business IntroductionGSK remains committed to achieving bold commercial ambitions for the future. By 2031 we aim to deliver 40 billion in annual sales leveraging our existing strong performance momentum to significantly increase our positive impact on the health of billions of patient

Business IntroductionGSK remains committed to achieving bold commercial ambitions for the future. By 2031 we aim to deliver 40 billion in annual sales leveraging our existing strong performance momentum to significantly increase our positive impact on the health of billions of patient

Business IntroductionGSK remains committed to achieving bold commercial ambitions for the future. By 2031 we aim to deliver 40 billion in annual sales leveraging our existing strong performance momentum to significantly increase our positive impact on the health of billions of patient

Business IntroductionGSK remains committed to achieving bold commercial ambitions for the future. By 2031 we aim to deliver 40 billion in annual sales leveraging our existing strong performance momentum to significantly increase our positive impact on the health of billions of patient

Business IntroductionGSK remains committed to achieving bold commercial ambitions for the future. By 2031 we aim to deliver 40 billion in annual sales leveraging our existing strong performance momentum to significantly increase our positive impact on the health of billions of patient

Business IntroductionGSK remains committed to achieving bold commercial ambitions for the future. By 2031 we aim to deliver 40 billion in annual sales leveraging our existing strong performance momentum to significantly increase our positive impact on the health of billions of patient